跳至主要内容
临床试验/NL-OMON49779
NL-OMON49779尚未招募不适用

Severe COVID-19 In Pregnancy (SCIP): a pilot study Linking disease severity to the maternal immune composition - SCIP pilot study

eids Universitair Medisch Centrum0 个研究点目标入组 8 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Three groups of women will be eligible for inclusion in this pilot study:
  • 1. COVID-19 during pregnancy: severe or critical disease
  • 2. COVID-19 during pregnancy: mild disease
  • 3. Healthy pregnant controls
  • 4. COVID-19: non-pregnant women (from BEAT-COVID-1 study)
  • Mild, severe and critical disease are classified using the definitions of the
  • WHO (WHO: Clinical management of severe acute respiratory infection when
  • COVID-19 is suspected, March 13, 2020):
  • -mild disease: hospital interventions is not required, only symptomatic
  • treatment (such as antipyretics for fever) and monitoring
  • -severe disease: hospitalization and oxygen therapy is required
  • -critical disease: acute respiratory distress syndrome (ARDS), advanced
  • oxygen/ventilatory support is required
  • Inclusion criteria group 1
  • - Laboratory confirmation of SARS-CoV-2 infection
  • - Severe or critical disease
  • - Laboratory confirmation of SARS-CoV-2 infection
  • - Mild disease
  • - Similar maternal age and gestational age as one of the patients in group 1
  • (matched as accurately as possible)
  • - Similar maternal age and gestational age as one of the patients in group 1
  • (matched as accurately as possible)

排除标准

  • 未提供

研究者

相似试验